The case study began in November 2025, when a private citizen noticed the gloves listed online and asked whether they might contain asbestos. The authors bought the item independently, two weeks apart, from the same retailer, and both purchases arrived within days. In December 2025 they removed fragments from each glove with laboratory tweezers and subjected them to X-ray powder diffraction and scanning electron microscopy equipped with energy-dispersive X-ray analysis. The diffraction patterns showed the fragments were dominated by chrysotile, the serpentine mineral with the ideal formula Mg3(OH)4Si2O5, mixed with the carbonate minerals calcite and dolomite. Quantification from the diffraction peak areas put the chrysotile content at an estimated 89.0, with an uncertainty of about 5.0, percent by weight.

Electron microscopy confirmed that the gloves were built from bundles of chrysotile fibres, identifiable by their characteristic silicon, magnesium and oxygen signature. More troubling still, the fibres met the morphological criteria used by the World Health Organization for regulated, respirable asbestos: at least 5 micrometres long, narrower than 3 micrometres, and with an aspect ratio of at least 3 to 1. In other words, the fibres were exactly the size range that can lodge deep in the lungs when inhaled. The authors note that when the gloves were handled they regrettably tended to release dust, meaning a consumer simply putting them on or taking them off could have been shedding asbestos fibres into their kitchen, garden or campsite.

For obvious privacy and legal reasons the researchers do not name the retailer, but they state that the analysed samples and product traceability data are preserved at the Department of Chemical and Geological Sciences in Modena. Their conclusion is blunt: the product does not comply with the asbestos regulations currently applicable in Italy, and the case should be reported to the competent authorities. The gloves’ journey from a Chinese manufacturer to an Italian doorstep, advertised without any hazard disclosure, illustrates precisely the gap the authors set out to document, one that digital commerce opens in regulatory regimes that took decades of public health advocacy to build.

Why is this still possible more than half a century after asbestos was definitively linked to mesothelioma and lung cancer? The answer lies in a regulatory asymmetry that persists at the heart of international trade. All six commercially recognised asbestos minerals, five amphibole species and the single serpentine species chrysotile, are classified by IARC as carcinogenic to humans. Yet only 74 of the world’s 195 countries, roughly 38 percent, have banned all asbestos types. The remaining majority still permit so-called controlled use of chrysotile, a concept the authors and many occupational health experts view with deep scepticism in real-world conditions. Major producers and consumers include Russia, China, India and Kazakhstan, economies where chrysotile remains an economic resource and political flashpoint.

This split produced what the authors call the global chrysotile issue. On one side stand legacy European manufacturers such as Eternit, which replaced asbestos with cellulose fibres decades ago and now face civil and criminal proceedings, including the notorious Italian maxi-trials in which thousands of plaintiffs confronted former managers of asbestos plants over occupational disease and environmental disaster. On the other side stand successor companies, often linked to the old European parent by name, such as SAMA in Brazil and Dadex Eternit Limited in Pakistan, which inherited the recipes for asbestos-cement products and continue to manufacture and export them. Meanwhile Brazil illustrates a second layer of fragmentation, with federal legislation historically permitting controlled chrysotile use while several states enacted outright bans on public health grounds.

The Rotterdam Convention, the treaty governing trade in hazardous chemicals, was meant to add a layer of transparency, but chrysotile has never been added to its Annex III, despite repeated recommendations by the Convention’s own Chemical Review Committee. Listing would not ban chrysotile outright; it would trigger the Prior Informed Consent procedure, obliging exporters to notify importers of the health risks and to respect their decisions. Because chrysotile remains unlisted, while all amphibole asbestos varieties are covered, shipments can move without mandatory warnings. At the most recent Conference of the Parties, COP12 in April and May 2025, consensus again failed and the matter was deferred to COP13, an impasse the authors attribute to political opposition by a small group of parties exploiting the treaty’s consensus-based listing practice.

The consequences cascade far beyond paperwork. Countries with comprehensive bans cannot reliably control imports and may unknowingly find asbestos-containing products on their territory, undermining their goal of zero exposure. Uninformed consumers, adults and children alike, handle hazardous goods without precautions, a risk thrown into sharp relief by the recent discovery of asbestos in children’s play sand sold in the United Kingdom, which a craft retailer withdrew from shelves after a parent’s alert, as reported by The Guardian in January 2026. Workers face a parallel hazard: companies that unknowingly import contaminated raw materials, as has occurred in the Italian ceramics industry with magnesite and other natural inputs, may expose employees without any possibility of health surveillance, and in jurisdictions like Italy can then face harsh legal and economic consequences when authorities detect the contamination. An extreme case involves war journalists, military personnel and NGO staff deployed to conflict zones, where bombing and demolition of asbestos-bearing buildings can release dense clouds of airborne fibres.

European law is tightening, though slowly. The CLP Regulation classifies asbestos as a carcinogenic substance with hazard codes H350 and H372, mandating labelling and secure packaging, and a 2024 update extends labelling requirements to distance sales, meaning online offers must clearly display hazard information. Yet the European Council has postponed the application of many of these provisions to January 1, 2028, and member states have improvised their own patches, such as Italy’s Consumer Code, which prohibits the sale of unlabelled or unsafe products. These measures govern what happens inside the EU; they do little to stop a product advertised on a global platform from being shipped across a border where it is illegal the moment it lands.

That is the authors’ central warning: asbestos should no longer be treated as a legacy hazard confined to old buildings, but as an evolving global risk sustained by economic globalisation, regulatory inconsistency and technological change. Digital marketplaces obscure responsibility, dilute accountability and complicate regulatory intervention in ways the Rotterdam Convention, designed for state-to-state trade, was never built to address. The authors call for a dedicated international framework for online asbestos sales, harmonised product identification, mandatory disclosure of asbestos content, platform accountability, cross-border enforcement and restrictions on sales to jurisdictions where asbestos is banned. Until then, they argue, the glove case may be just the tip of an iceberg, one small glimpse of a massive and largely invisible global traffic in carcinogenic goods.

Subject of Research: Online sale and cross-border circulation of asbestos-containing consumer products and the regulatory gaps enabling them

Article Title: Banned here, sold elsewhere: globalization, e-commerce and the continuing circulation of asbestos-containing products

Article References: Banned here, sold elsewhere: globalization, e-commerce and the continuing circulation of asbestos-containing products. (n.d.). https://doi.org/10.1186/s12940-026-01348-x

Image Credits: AI Generated

DOI: 10.1186/s12940-026-01348-x

Keywords: asbestos, chrysotile, e-commerce, Rotterdam Convention, regulation, public health, consumer products, IARC carcinogen, environmental health, global trade, exposure, EU chemicals law